https://endeavorbiomedicines.com/wp-content/uploads/Screenshot-2023-06-20-at-11.14.24-AM-e1687284949348.png
1020
1857
Fiona Meyer
/wp-content/uploads/logo.png
Fiona Meyer2023-06-20 11:11:192023-06-21 14:07:45Inside the Blueprint: New Tools to Uncover the Genetic Culprits of Cancer
https://endeavorbiomedicines.com/wp-content/uploads/Eneavor_PTCH-1_LOF_Screenshot-1.png
788
1400
David Anderson
/wp-content/uploads/logo.png
David Anderson2022-10-14 09:55:192022-11-02 17:28:32Next-Generation Sequencing (NGS) & PTCH-1 Loss-of-Function (LOF)
https://endeavorbiomedicines.com/wp-content/uploads/Balancing_Act_Screencap.png
717
1280
David Anderson
/wp-content/uploads/logo.png
David Anderson2022-10-18 09:43:532022-11-03 12:24:14The Balancing Act – The Future of Cancer Treatments: How Next Generation Sequencing can Optimize Treatments
https://endeavorbiomedicines.com/wp-content/uploads/Xcures-Target-Cancer-Podcast-Endeavor-Biomedicines.png
838
1489
David Anderson
/wp-content/uploads/logo.png
David Anderson2022-10-14 09:55:562022-11-02 17:12:26xCures Target Cancer Podcast
Scroll to top
